A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

Project: Other project

Project Details

StatusActive
Effective start/end date12/8/21 → 12/7/26

Funding

  • Genentech Inc.: $10,109.23